Ocular Therapeutix (OCUL) 2025 Conference May 20, 2025 02:35 PM ET Speaker0 Capital Markets and it is our great privilege to have Ocular Therapeutics joining us for a fireside chat. Representing the company we have Praveen Dugal, Executive Chair, President, and CEO. Praveen, thanks so much for joining us. How are you doing today? Speaker1 Great, Lisa, and thank you. Thank you for having us on this great conference. An honor to be here, and thank you for the invitation. Speaker0 Excellent. Well, Praveen, jus ...

J P M O R G A N Asia Pacific Equity Research 12 May 2025 China Healthcare Quick thoughts on the potential impact of Trump's US drug pricing change proposal on the China drug industry According to news articles, President Trump is expected to sign an executive order to reduce US drug prices by 30-80%, following a "most favored nation" pricing model. As this was reported a few days ago, please refer to our US pharma analysts Chris Schott's and Lisa Gill's previous notes on drug pricing for more context. We've ...

President Trump took aim at Big Pharma on Monday by signing an executive order meant to slash Americans’ prescription drug prices by up to 90% — sparking a selloff in companies he labeled as “middlemen.” “What’s been happening is, we’ve been subsidizing other countries throughout the world,” Trump explained at a White House signing ceremony, calling the action one of his “most important orders.”“Some prescription drug and pharmaceutical prices will be reduced almost immediately by 50 to 80 to 90%,” he added ...